NCT00561327View on ClinicalTrials.gov

PPARgamma Activation by Losartan in Hypertensive Patients: The Importance of Losartan-Metabolites

UnknownOBSERVATIONAL
Timeline

Start Date

September 30, 2007

Conditions
Hypertension
Interventions
DRUG

losartan

Daily treated with losartan 100mg for at least the past 2 months (retrospective, no new drug treatment/ intervention)

Trial Locations (1)

13353

RECRUITING

German Heart Institute, Berlin

Sponsors
All Listed Sponsors
collaborator

Charite University, Berlin, Germany

OTHER

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

German Heart Institute

OTHER

NCT00561327 - PPARgamma Activation by Losartan in Hypertensive Patients: The Importance of Losartan-Metabolites | Biotech Hunter | Biotech Hunter